KOD
Price
$7.17
Change
-$0.47 (-6.15%)
Updated
Jan 17 closing price
Capitalization
377.31M
67 days until earnings call
QNCX
Price
$1.66
Change
-$0.06 (-3.49%)
Updated
Jan 17 closing price
Capitalization
73.04M
44 days until earnings call
Ad is loading...

KOD vs QNCX

Header iconKOD vs QNCX Comparison
Open Charts KOD vs QNCXBanner chart's image
Kodiak Sciences
Price$7.17
Change-$0.47 (-6.15%)
Volume$303.23K
Capitalization377.31M
Quince Therapeutics
Price$1.66
Change-$0.06 (-3.49%)
Volume$185.01K
Capitalization73.04M
KOD vs QNCX Comparison Chart
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. QNCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Hold and QNCX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (KOD: $7.17 vs. QNCX: $1.66)
Brand notoriety: KOD and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 63% vs. QNCX: 77%
Market capitalization -- KOD: $377.31M vs. QNCX: $73.04M
KOD [@Biotechnology] is valued at $377.31M. QNCX’s [@Biotechnology] market capitalization is $73.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileQNCX’s FA Score has 1 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • QNCX’s FA Score: 1 green, 4 red.
According to our system of comparison, both KOD and QNCX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 2 TA indicator(s) are bullish while QNCX’s TA Score has 2 bullish TA indicator(s).

  • KOD’s TA Score: 2 bullish, 5 bearish.
  • QNCX’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, QNCX is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а -13.82% price change this week, while QNCX (@Biotechnology) price change was -7.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

KOD is expected to report earnings on May 14, 2025.

QNCX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($377M) has a higher market cap than QNCX($73M). QNCX YTD gains are higher at: -11.230 vs. KOD (-27.940). QNCX has higher annual earnings (EBITDA): -33.93M vs. KOD (-164.93M). KOD has more cash in the bank: 198M vs. QNCX (47.8M). QNCX has less debt than KOD: QNCX (15.4M) vs KOD (73.4M). KOD (0) and QNCX (0) have equivalent revenues.
KODQNCXKOD / QNCX
Capitalization377M73M516%
EBITDA-164.93M-33.93M486%
Gain YTD-27.940-11.230249%
P/E RatioN/AN/A-
Revenue00-
Total Cash198M47.8M414%
Total Debt73.4M15.4M477%
FUNDAMENTALS RATINGS
KOD: Fundamental Ratings
KOD
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KODQNCX
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
89%
Bearish Trend 11 days ago
72%
Momentum
ODDS (%)
Bearish Trend 11 days ago
77%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
Bearish Trend 11 days ago
87%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
85%
Bullish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
89%
Bullish Trend 11 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 17 days ago
87%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
84%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EE32.330.30
+0.94%
Excelerate Energy
WSBC31.940.23
+0.73%
WesBanco
ENSG136.790.46
+0.34%
Ensign Group (The)
AVTX6.750.02
+0.30%
Avalo Therapeutics
HON222.58-0.11
-0.05%
Honeywell International

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
-6.15%
IMNM - KOD
42%
Loosely correlated
+1.32%
AKBA - KOD
39%
Loosely correlated
+7.25%
RCKT - KOD
39%
Loosely correlated
+0.98%
NUVB - KOD
38%
Loosely correlated
-1.18%
PLRX - KOD
38%
Loosely correlated
-3.36%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-3.49%
MNPR - QNCX
35%
Loosely correlated
-6.36%
CCCC - QNCX
33%
Poorly correlated
+2.07%
ADCT - QNCX
31%
Poorly correlated
+4.57%
CLNN - QNCX
29%
Poorly correlated
-2.04%
KOD - QNCX
28%
Poorly correlated
-6.15%
More